Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Stearamidoethyl Diethylamine Hydrobromide
2. Stearamidoethyl Diethylamine Phosphate
1. 16889-14-8
2. Lexamine 22
3. N-(2-(diethylamino)ethyl)stearamide
4. N-[2-(diethylamino)ethyl]stearamide
5. N-[2-(diethylamino)ethyl]octadecanamide
6. Octadecanamide, N-[2-(diethylamino)ethyl]-
7. Octadecanamide, N-(2-(diethylamino)ethyl)-
8. 25ffj4209z
9. Stearic Acid-n,n-diethylethylenediamine Condensate
10. Nsc-126195
11. N-(2-(diethylamino)ethyl)octadecanamide
12. Diethylaminoethyl Stearamide
13. Sapamine Cob-st (van)
14. Unii-25ffj4209z
15. Sapamine Cob-st
16. Einecs 240-924-3
17. Nsc 126195
18. Chemical Base 6532
19. Diethylaminoethylstearamide
20. Schembl74483
21. Dtxsid9066128
22. Nsc126195
23. Akos022181126
24. Zinc100066655
25. Stearamidoethyl Diethylamine [ii]
26. Stearic Acid Diethylaminoethylamide
27. Stearamidoethyl Diethylamine [inci]
28. Stearamidoethyl Diethylamine [vandf]
29. Ft-0716114
30. Q27253955
| Molecular Weight | 382.7 g/mol |
|---|---|
| Molecular Formula | C24H50N2O |
| XLogP3 | 8.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 21 |
| Exact Mass | 382.392314223 g/mol |
| Monoisotopic Mass | 382.392314223 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 303 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
66
PharmaCompass offers a list of Lexamine 22 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lexamine 22 manufacturer or Lexamine 22 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lexamine 22 manufacturer or Lexamine 22 supplier.
PharmaCompass also assists you with knowing the Lexamine 22 API Price utilized in the formulation of products. Lexamine 22 API Price is not always fixed or binding as the Lexamine 22 Price is obtained through a variety of data sources. The Lexamine 22 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lexamine 22 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lexamine 22, including repackagers and relabelers. The FDA regulates Lexamine 22 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lexamine 22 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lexamine 22 supplier is an individual or a company that provides Lexamine 22 active pharmaceutical ingredient (API) or Lexamine 22 finished formulations upon request. The Lexamine 22 suppliers may include Lexamine 22 API manufacturers, exporters, distributors and traders.
Lexamine 22 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lexamine 22 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lexamine 22 GMP manufacturer or Lexamine 22 GMP API supplier for your needs.
A Lexamine 22 CoA (Certificate of Analysis) is a formal document that attests to Lexamine 22's compliance with Lexamine 22 specifications and serves as a tool for batch-level quality control.
Lexamine 22 CoA mostly includes findings from lab analyses of a specific batch. For each Lexamine 22 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lexamine 22 may be tested according to a variety of international standards, such as European Pharmacopoeia (Lexamine 22 EP), Lexamine 22 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lexamine 22 USP).
